US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.805
  • -0.002-0.28%
Trading Nov 21 13:37 ET
291.04MMarket Cap-1087P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
Operating revenue
980.25%1.75M
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
Cost of revenue
914.29%71K
1,975.00%166K
31K
85K
70K
7K
8K
0
0
0
Gross profit
983.23%1.68M
379.29%1.48M
4,479.17%1.1M
705.04%1.12M
2,157.14%632K
297.44%155K
782.86%309K
24K
-53.36%139K
28K
Operating expense
31.31%65.37M
27.58%56.84M
48.98%46.43M
71.33%172.87M
56.30%47.37M
115.21%49.79M
85.30%44.55M
33.09%31.17M
15.46%100.9M
19.58%30.31M
Selling and administrative expenses
22.85%39.59M
30.61%39.19M
67.50%32.06M
137.05%113.98M
99.69%32.61M
156.25%32.23M
180.82%30.01M
125.42%19.14M
48.67%48.08M
84.59%16.33M
-General and administrative expense
----
----
67.50%32.06M
----
----
----
----
125.42%19.14M
----
----
Research and development costs
46.83%25.78M
21.33%17.64M
19.51%14.37M
11.49%58.89M
5.62%14.76M
66.32%17.56M
8.87%14.54M
-19.43%12.03M
-4.05%52.82M
-15.28%13.98M
Operating profit
-28.33%-63.69M
-25.12%-55.35M
-45.57%-45.33M
-70.45%-171.75M
-54.36%-46.74M
-114.90%-49.63M
-84.28%-44.24M
-33.20%-31.14M
-15.70%-100.76M
-19.53%-30.28M
Net non-operating interest income expense
-25.06%-1.12M
389.91%1.93M
-286.87%-3.06M
-353.46%-5.37M
-1,297.69%-3.02M
-206.16%-894K
-14.48%-664K
-725.00%-792K
-77.25%-1.18M
23.13%-216K
Non-operating interest income
14.61%3.44M
219.14%4.14M
83.09%1.88M
384.46%7.73M
170.80%2.4M
425.35%3.01M
953.66%1.3M
7,250.00%1.03M
1,091.04%1.6M
6,235.71%887K
Non-operating interest expense
17.00%4.56M
12.81%2.21M
171.72%4.95M
371.26%13.1M
391.48%5.42M
351.27%3.9M
178.81%1.96M
1,555.45%1.82M
246.63%2.78M
273.90%1.1M
Other net income (expense)
Income before tax
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Income tax
Net income
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Net income continuous Operations
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Minority interest income
Net income attributable to the parent company
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
Basic earnings per share
14.29%-0.18
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
Diluted earnings per share
14.29%-0.18
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 980.25%1.75M419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K
Operating revenue 980.25%1.75M419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K
Cost of revenue 914.29%71K1,975.00%166K31K85K70K7K8K000
Gross profit 983.23%1.68M379.29%1.48M4,479.17%1.1M705.04%1.12M2,157.14%632K297.44%155K782.86%309K24K-53.36%139K28K
Operating expense 31.31%65.37M27.58%56.84M48.98%46.43M71.33%172.87M56.30%47.37M115.21%49.79M85.30%44.55M33.09%31.17M15.46%100.9M19.58%30.31M
Selling and administrative expenses 22.85%39.59M30.61%39.19M67.50%32.06M137.05%113.98M99.69%32.61M156.25%32.23M180.82%30.01M125.42%19.14M48.67%48.08M84.59%16.33M
-General and administrative expense --------67.50%32.06M----------------125.42%19.14M--------
Research and development costs 46.83%25.78M21.33%17.64M19.51%14.37M11.49%58.89M5.62%14.76M66.32%17.56M8.87%14.54M-19.43%12.03M-4.05%52.82M-15.28%13.98M
Operating profit -28.33%-63.69M-25.12%-55.35M-45.57%-45.33M-70.45%-171.75M-54.36%-46.74M-114.90%-49.63M-84.28%-44.24M-33.20%-31.14M-15.70%-100.76M-19.53%-30.28M
Net non-operating interest income expense -25.06%-1.12M389.91%1.93M-286.87%-3.06M-353.46%-5.37M-1,297.69%-3.02M-206.16%-894K-14.48%-664K-725.00%-792K-77.25%-1.18M23.13%-216K
Non-operating interest income 14.61%3.44M219.14%4.14M83.09%1.88M384.46%7.73M170.80%2.4M425.35%3.01M953.66%1.3M7,250.00%1.03M1,091.04%1.6M6,235.71%887K
Non-operating interest expense 17.00%4.56M12.81%2.21M171.72%4.95M371.26%13.1M391.48%5.42M351.27%3.9M178.81%1.96M1,555.45%1.82M246.63%2.78M273.90%1.1M
Other net income (expense)
Income before tax -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Income tax
Net income -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Net income continuous Operations -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Minority interest income
Net income attributable to the parent company -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M
Basic earnings per share 14.29%-0.1822.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.16
Diluted earnings per share 14.29%-0.1822.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data